Stock listing

Entheon Biomedical Corp.

Selected listing: 1XU · MUN · EUR · DE

Entheon Biomedical Corp. (Munich:1XU), Health Technology. Latest release Sep 11, 2026: Entheon Adopts Semi-Annual Reporting.

1XU:MUNEURDEUpdated September 26, 2026

Ticker: Munich:1XU
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

About Entheon Biomedical Corp.

Entheon Biomedical Corp. (Ticker: ENBI) is a public company based in Canada, focusing on the development of psychedelic therapies for mental health conditions. Entheon aims to advance its research and development efforts in the growing field of psychedelic medicine.

Latest news from Entheon Biomedical Corp.

Entheon Adopts Semi-Annual Reporting

September 11, 2026

Entheon Announces Execution of Business Combination Agreement with Nutravisor

January 19, 2026

Entheon Announces Letter of Intent with Nutravisor Inc.

December 22, 2025

Entheon Announces Change of Directors

April 3, 2025

Entheon Issues Incentive Stock Options

March 31, 2025

All Entheon Biomedical Corp. news →

Research Entheon Biomedical Corp.

Entheon Biomedical Corp. company profile

View the public company page for Entheon Biomedical Corp. on 6ix.

Entheon Biomedical Corp. news

Read company news and market updates connected to Entheon Biomedical Corp..

Entheon Biomedical Corp. investor events

Find investor webinars, events, and replay context for Entheon Biomedical Corp..